Spectroscopically detectable nucleic acid ligands
First Claim
1. A method for determining the presence of a target compound in a sample, said target compound selected from the group consisting of proteins, peptides, cell surface markers, carbohydrates, polysaccharides, glycoproteins, hormones, receptors, antigens, antibodies, co-factors, inhibitors, drugs, dyes, nutrients, growth factors, amino acids, ATP, theophylline, whole cells and viral particles comprising:
- (a) measuring at least one of the fluorescence polarization, anisotropy values or rotational correlation times of a spectroscopically detectable labeled nucleic acid ligand to said target compound,(b) adding to the sample the spectroscopically detectable labeled nucleic acid ligand whereby the nucleic acid ligand binds to the target compound; and
(c) determining whether there is a difference between at least one of the fluorescence polarization, anisotropy values or rotational correlation times of (i) the mixture of spectroscopically detectable nucleic acid ligand bound to the target compound and sample in (b), and (ii) the spectroscopically detectable nucleic acid ligand alone in (a) whereby an increase in at least one of the fluorescence polarization, anisotropy values or rotational correlation times in the mixture relative to the nucleic acid ligand alone is indicative of the presence of the target compound in the sample.
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to methods of using spectroscopically detectable labeled receptor molecules to determine the presence or absence of a target compound in a sample. In one embodiment, spectroscopically detectable labeled nucleic acid ligands are used to determine the presence or absence of biological targets of interest in biological samples.
59 Citations
36 Claims
-
1. A method for determining the presence of a target compound in a sample, said target compound selected from the group consisting of proteins, peptides, cell surface markers, carbohydrates, polysaccharides, glycoproteins, hormones, receptors, antigens, antibodies, co-factors, inhibitors, drugs, dyes, nutrients, growth factors, amino acids, ATP, theophylline, whole cells and viral particles comprising:
-
(a) measuring at least one of the fluorescence polarization, anisotropy values or rotational correlation times of a spectroscopically detectable labeled nucleic acid ligand to said target compound, (b) adding to the sample the spectroscopically detectable labeled nucleic acid ligand whereby the nucleic acid ligand binds to the target compound; and (c) determining whether there is a difference between at least one of the fluorescence polarization, anisotropy values or rotational correlation times of (i) the mixture of spectroscopically detectable nucleic acid ligand bound to the target compound and sample in (b), and (ii) the spectroscopically detectable nucleic acid ligand alone in (a) whereby an increase in at least one of the fluorescence polarization, anisotropy values or rotational correlation times in the mixture relative to the nucleic acid ligand alone is indicative of the presence of the target compound in the sample. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)
-
-
35. A method of monitoring the binding of a target compound to its receptor in a sample using a spectroscopically detectable nucleic acid ligand to the receptor in a competition-based assay, comprising:
-
(a) measuring the spectroscopic emissions of the spectroscopically detectable nucleic acid ligand; (b) mixing the spectroscopically detectable nucleic acid ligand with the sample, whereby the spectroscopically detectable nucleic acid ligand binds to the receptor in competition with the target compound; (c) measuring the spectroscopic emissions of the complex of the spectroscopically detectable nucleic acid ligand bound to the receptor of step (b); (d) determining the degree of binding of the spectroscopically detectable nucleic acid ligand to the receptor from the spectroscopic emissions measured in step (c); and (e) calculating the degree of binding of target compound to its receptor from the determination of step (d). - View Dependent Claims (36)
-
Specification